In the BioHarmony Drug Report Database

"Preview" Icon

Tolazoline

Priscoline (tolazoline) is a small molecule pharmaceutical. Tolazoline was first approved as Priscoline on 1985-02-22. It is used to treat arteriosclerosis obliterans, causalgia, peripheral vascular diseases, persistent fetal circulation syndrome, and raynaud disease amongst others in the USA. The pharmaceutical is active against alpha-2C adrenergic receptor, alpha-2B adrenergic receptor, and alpha-2A adrenergic receptor.

 

Trade Name

 

Priscoline
 

Common Name

 

tolazoline
 

ChEMBL ID

 

CHEMBL770
 

Indication

 

arteriosclerosis obliterans, causalgia, peripheral vascular diseases, persistent fetal circulation syndrome, raynaud disease, spasm, systemic scleroderma, thromboangiitis obliterans, thrombophlebitis
 

Drug Class

 

Antihistamines/local vasoconstrictors (antazoline type)

Image (chem structure or protein)

Tolazoline structure rendering